Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,909 public trials 2,181 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03636269

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +16 more
Locations
  • Cara Therapeutics Study Site Chula Vista, California, United States
  • Cara Therapeutics Study Site Fountain Valley, California, United States
  • Cara Therapeutics Study Site Northridge, California, United States
  • Cara Therapeutics Study Site Riverside, California, United States
View all 92 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

NCT03422653

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +16 more
Locations
  • Cara Therapeutics Study Site Homewood, Alabama, United States
  • Cara Therapeutics Study Site Huntsville, Alabama, United States
  • Cara Therapeutics Study Site Bakersfield, California, United States
  • Cara Therapeutics Study Site 2 Beverly Hills, California, United States
View all 57 locations
View Trial Details
Completed

A Study of RG-012 in Subjects With Alport Syndrome

NCT03373786

Conditions
Alport Syndrome, Collagen Diseases, Congenital Abnormalities, +12 more
Locations
  • eStudySite La Mesa, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • Apex Research of Riverside Riverside, California, United States
  • Eminence Medical & Clinical Research Tampa, Florida, United States
View Trial Details
Completed

Preserve-Transplant Study

NCT03102996

Conditions
Acid-Base Imbalance, Acidosis, Chronic Disease, +14 more
Locations
  • Inselspital Bern, Department of Nephrology and Hypertension Bern, Canton of Bern, Switzerland
  • HUG - Néphrologie Geneva, Canton of Geneva, Switzerland
  • University Hospital Zurich, Division of Nephrology Zurich, Canton of Zurich, Switzerland
View Trial Details
Completed

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

NCT02315066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +60 more
Locations
  • The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • LAC+USC Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions